Global longitudinal strain

There are 110 papers on global longitudinal strain in aging research: 11 trials and 69 observational studies in people, 10 in animals, 18 reviews. The newest story, Nov 7, 2026: “Blocking a collagen-linking enzyme improved heart failure in rats”.

Biomarker

110 papers study it86 more mention it37 findings

MeSH

64 new papers in 30 daysSee all 196 papers on global longitudinal strain

“GLS (HR 1.22, 95%CI 1.13-1.31), GRS (0.88, 0.80-0.96), and GCS (1.27, 1.15-1.40) were independently associated with AF (all P < 0.01)”
Associations of Integrated Left Ventricular Myocardial Strain Metrics and Incident Atrial FibrillationCJC open2025doi:10.1016/j.cjco.2025.11.012
  • Human trial11
  • Humans69
  • Animals10

Interventions

6

SGLT2 inhibitors

upin humans4

4 studies
  1. SGLT2 inhibitors improve global longitudinal strain in humans (4% improvement versus 2.2% with multiple daily injections; P<0.05).

    “Hybrid closed-loop systems and SGLT-2i group displayed the most significant improvement in GLS (6.7 % and 4 %)”

    Human trialPoorly controlled type 1 diabetes; SGLT-2i added to multiple daily injections versus intensified multiple daily injectionsmyocardium12 months

    Effects of hybrid closed-loop systems and SGLT2i on myocardial deformation and vascular function in type 1 diabetics

    ESC Congress 2026 abstract

  2. SGLT2 inhibitors are linked with better global longitudinal strain in humans (compared with control group not receiving SGLT2i) (ΔGLS -2.49% ± 0.54% vs -0.44% ± 0.52%).

    “GLS improved significantly (ΔGLS: -2.49% ± 0.54% vs. -0.44% ± 0.52%, P < 0.001)”

    Humanscompared with control group not receiving SGLT2iheart6 monthsn = 185

    Long-term SGLT2 inhibitor therapy improves myocardial strain and diastolic function in HFpEF: a retrospective study linking functional recovery to reduced myocardial fibrosis

    Frontiers in cardiovascular medicine

  3. SGLT2 inhibitors are linked with better global longitudinal strain in humans (normal weight: -17.83 ± 1.30% to -19.22 ± 1.20%; overweight/obesity: -17.70 ± 1.48% to -19.05 ± 1.24%).

    “Both groups showed significant GLS improvement (normal weight: -17.83 ± 1.30% to -19.22 ± 1.20%; overweight/obesity: -17.70 ± 1.48% to -19.05 ± 1.24%; both p < 0.001)”

    Humans6 monthsn = 614

    SGLT2 inhibitors improve subclinical left ventricular systolic function independent of body mass index in patients with type 2 diabetes: A prospective strain imaging study

    Diabetes research and clinical practice

  4. SGLT2 inhibitors improve global longitudinal strain in humans (moderate or severe complexity ACHD) (mean difference -1.6 [-2.4,-0.9]).

    “SGLT2i therapy was associated with a statistically significant improvement in GLS (mean difference -1.6 [-2.4,-0.9])”

    Reviewmoderate or severe complexity ACHDn = 174

    Sodium glucose co-transport inhibitors to treat heart failure in patients with complex adult congenital heart disease - a systematic review and meta-analysis

    medRxivPreprint

More on SGLT2 inhibitors

Dapagliflozin

downin humans1upin humans1

2 studies
  1. Dapagliflozin improves global longitudinal strain in humans (non-diabetic patients with AMI after PCI) (Δ-1.467 ± 3.023% vs Δ-0.475 ± 2.252%).

    “GLS change was significantly greater in Group I (Δ-1.467 ± 3.023 % vs. Δ-0.475 ± 2.252%; p = 0.009).”

    Human trialnon-diabetic patients with AMI after PCIleft ventricle6 months

    Early Dapagliflozin in Non-diabetic Acute Myocardial Infarction Patients Post-PCI: Effects on Cardiovascular Outcomes and Left Ventricular Remodeling (EARLY DAPA-AMI)

    Journal of the Saudi Heart Association

  2. Dapagliflozin is linked with lower global longitudinal strain in humans (Between-group difference -1.34 percentage points (95% CI -1.72 to -0.97); Cohen's d = 0.875).

    “Compared with controls, dapagliflozin decreased GLS (between-group Δ: -1.34%, 95% CI: -1.72 to -0.97; Cohen's d = 0.875)”

    Humansheart failure with preserved ejection fraction and chronic kidney disease; compared with conventional therapy without SGLT2iheart10 mg/day6 monthsn = 259

    Effect of dapagliflozin on left ventricular longitudinal strain and atrioventricular coupling in heart failure with preserved ejection fraction and chronic kidney disease

    BMC cardiovascular disorders

More on Dapagliflozin

Hybrid closed-loop system

upin humans1

1 study
  1. Hybrid closed-loop system improves global longitudinal strain in humans (Poorly controlled type 1 diabetes; compared with intensified multiple daily injections) (6.7% improvement versus 2.2% with multiple daily injections; P<0.05).

    “Hybrid closed-loop systems and SGLT-2i group displayed the most significant improvement in GLS (6.7 % and 4 %)”

    Human trialPoorly controlled type 1 diabetes; compared with intensified multiple daily injectionsmyocardium12 months

    Effects of hybrid closed-loop systems and SGLT2i on myocardial deformation and vascular function in type 1 diabetics

    ESC Congress 2026 abstract

More on Hybrid closed-loop system

Insulin resistance

downin humans1

1 study
  1. Insulin resistance is linked with lower global longitudinal strain in humans (Q4 vs. Q1) (MD -1.58 percentage points (95% CI: -2.22 to -0.93)).

    “The random-effects pooled MD in GLS (Q4 vs. Q1) was -1.58 percentage points (95% CI: -2.22 to -0.93), indicating a lower strain magnitude (worse subclinical systolic function) in the highest IR group.”

    HumansQ4 vs. Q1left ventricle

    Insulin Resistance Indices and Subclinical Left Ventricular Systolic Dysfunction in Adults: A Systematic Review and Meta-Analysis

    Reviews in cardiovascular medicine

More on Insulin resistance

Glucocorticoids

downin Papio1

1 study
  1. Glucocorticoids decrease global longitudinal strain in utero exposure.

    “In sGC-exposed males, global longitudinal strain (GLS) decreased with age versus CTR (P = 0.03)”

    Animalsin utero exposureheartmales

    Prenatal glucocorticoid exposure programs long-term left ventricular metabolism, function, and remodeling in baboons

    American journal of physiology. Heart and circulatory physiology

More on Glucocorticoids

Dulaglutide

upin humans1

1 study
  1. Dulaglutide improves global longitudinal strain in humans (metformin-treated T2DM and prior ischemic stroke) (14.7% vs. 8.3%, p = 0.024).

    “dulaglutide resulted in a greater increase in GLS (14.7% vs. 8.3%, p = 0.024) compared to empagliflozin”

    Human trialmetformin-treated T2DM and prior ischemic stroke12 monthsn = 54

    Vascular and Myocardial Function in Patients with Type 2 Diabetes and Ischemic Stroke Treated with Dulaglutide or Empagliflozin

    Medicina (Kaunas, Lithuania)

More on Dulaglutide

Upstream

1

Menopause

no changein humans1

1 study
  1. Menopause was not clearly linked with global longitudinal strain in humans (menopausal versus perimenopausal women) (−19.62 ± 2.08% vs. −19.50 ± 1.96%; p = 0.723).

    “GLS was similar in menopausal and perimenopausal women (−19.62 ± 2.08% vs. −19.50 ± 1.96%; p = 0.723)”

    Humansmenopausal versus perimenopausal womenleft ventricular myocardiumfemalesn = 153

    Early Changes in Myocardial Mechanics and Diastolic Function in Women During the Menopausal Transition

    Journal of clinical medicine

Associations

23

Mortality

downin humans3HR 0.94–0.95

3 studies
  1. Global longitudinal strain is linked with a lower risk of mortality in humans (acute heart failure) (HR:0.94, 95%CI:0.89-0.99, p = 0.045).

    “Higher GLS, LAr, and LAcd were associated with a lower risk of mortality (HR:0.94, 95%CI:0.89-0.99, p = 0.045”

    Humansacute heart failureheartmedian follow-up time of 39 (IQR 14-66) monthsn = 141

    Left ventricular and atrial strain and the risk of mortality and rehospitalization in heart failure

    Echo research and practice

  2. Global longitudinal strain predicts mortality in humans (transthyretin cardiac amyloidosis) (HR 0.95, 95% CI 0.922-0.989).

    “global longitudinal strain (HR = 0.95, 95% CI: [0.922-0.989]”

    Humanstransthyretin cardiac amyloidosis

    Phenotype and prognostic factors in geriatric and non-geriatric patients with transthyretin cardiomyopathy

    ESC heart failure

  3. Mortality is associated with global longitudinal strain in humans (-19.2 ± 4.3 vs. -20.6 ± 3.5%).

    “Subjects with adverse outcomes had significantly lower LV GLS (dead vs. alive; - 19.2 ± 4.3 vs. - 20.6 ± 3.5%, p < 0.05) and PALS (32.3 ± 12.0 vs. 41.8 ± 14.2%, p < 0.001)”

    Humansmedian follow-up of 9.5 yearsn = 314

    Long-term prognostic value of left atrial longitudinal strain in an elderly community-based cohort

    GeroScience

Incident heart failure

upin humans2HR 2.26–4.09

2 studies
  1. Global longitudinal strain is associated with incident heart failure in humans (HR 4.09, 95% CI 1.87–8.92).

    “impaired GLS (<-18%) conferred a hazard ratio of 4.09 (95% CI 1.87-8.92) for incident HF.”

    Humansat-risk populations with preserved or mildly reduced ejection fraction; impaired GLS (<-18%)heartn = 447

    A Restricted Cubic Spline Analysis of Continuous Global Longitudinal Strain (GLS) and the Non-Linear Risk of Incident Heart Failure

    AHA Scientific Sessions 2026 abstract

  2. Global longitudinal strain is associated with incident heart failure in humans (Reduced GLS (>–16%); independent association beyond PREVENT) (HR 2.26 (95% CI 1.92–2.66)).

    “Both markers were independently associated with HF: reduced GLS (>–16%) HR 2.26 (95% CI 1.92-2.66; p<0.001)”

    HumansReduced GLS (>–16%); independent association beyond PREVENTheartMedian follow-up 4.8 years47.4% malesn = 1,396

    Tiered Echocardiographic Reclassification Beyond PREVENT: Differential Utility of Global Longitudinal Strain and Peak Myocardial Work Across PREVENT Heart Failure Risk Strata

    AHA Scientific Sessions 2026 abstract

More on Incident heart failure

Incident heart failure and cardiovascular death

upin humans1HR 1.16

1 study
  1. Global longitudinal strain is associated with incident heart failure and cardiovascular death in humans (per 1% decrease in global longitudinal strain magnitude) (HR 1.16, 95% CI 1.02–1.31 per 1% decrease in GLS).

    “a hazard ratio of 1.16 (95% CI 1.02-1.31) per 1% decrease in GLS for incident HF and cardiovascular death.”

    Humansper 1% decrease in global longitudinal strain magnitudeheartn = 4,013

    A Restricted Cubic Spline Analysis of Continuous Global Longitudinal Strain (GLS) and the Non-Linear Risk of Incident Heart Failure

    AHA Scientific Sessions 2026 abstract

Incident atrial fibrillation

upin humans1HR 1.13

1 study
  1. Global longitudinal strain predicts incident atrial fibrillation in humans (HR 1.13 per 1% decrease in GLS; 95% CI 1.01–1.27).

    “After multivariable adjustment for clinical and echocardiographic parameters, the association remained significant in men (per 1% decrease: HR 1.13; 95% CI (1.01-1.27), p=0.038)”

    HumansMultivariable-adjusted association; free of atrial fibrillation, heart failure, and prior stroke at baselineleft ventricleMedian follow-up of 5 yearsmales

    Sex-specific echocardiographic predictors of atrial fibrillation in the general population

    ESC Congress 2026 abstract

More on Incident atrial fibrillation

Ischemic stroke

mixedin humans1OR 0.9

1 study
  1. Global longitudinal strain predicts ischemic stroke in humans (OR 0.90, 95% CI 0.81–0.99; described as impaired strain predicting stroke).

    “impaired GLS (OR 0.90, 95% CI 0.81–0.99) as independent predictors of ischemic stroke.”

    Humansn = 603

    Unmasking the silent threat: essential hypertension as a catalyst for ischemic stroke through atrial myopathy

    ESC Congress 2026 abstract

More on Ischemic stroke

Major adverse cardiovascular events

upin humans1

1 study
  1. Global longitudinal strain is associated with major adverse cardiovascular events in humans (Increased risk confined to lower strain values).

    “GLS demonstrated a non-linear association with MACE, with increased risk confined to lower strain values.”

    HumansIncreased risk confined to lower strain valuesheartMedian follow-up of 8.3 yearsn = 2,495

    Global longitudinal strain and mechanical dispersion predict cardiovascular events in a middle-aged population: the ACE1950 study

    ESC Congress 2026 abstract

Preeclampsia

upin humans1

1 study
  1. Preeclampsia is associated with global longitudinal strain in humans (postpartum; previous preeclampsia compared with controls) (GLS MD 2.39 (95% CI 1.48 to 3.29); LVEF MD -2.76 (95% CI -4.61 to -0.90)).

    “and also in women with PE (MD 2.39 [CI 95%: 1.48 to 3.29]; p<0.00001; I2 29% - Figure 1B).”

    Reviewpostpartum; previous preeclampsia compared with controlsleft ventriclefemales

    Left ventricular dysfunction following pregnancy with hypertensive disorders - a systematic review and meta-analysis

    ESC Congress 2026 abstract

More on Preeclampsia

Hypertensive disorders of pregnancy

upin humans1

1 study
  1. Hypertensive disorders of pregnancy is associated with global longitudinal strain in humans (postpartum; previous hypertensive disorders of pregnancy compared with controls) (GLS MD 1.23 (95% CI 0.60 to 1.85)).

    “Postpartum GLS was significantly impaired in women with previous HDP compared with controls”

    Reviewpostpartum; previous hypertensive disorders of pregnancy compared with controlsleft ventriclefemales

    Left ventricular dysfunction following pregnancy with hypertensive disorders - a systematic review and meta-analysis

    ESC Congress 2026 abstract

More on Hypertensive disorders of pregnancy

HIV infection

downin humans1

1 study
  1. HIV infection is associated with global longitudinal strain in humans.

    “HIV patients showed significantly lower values of global longitudinal strain of the left ventricle, right ventricle free wall and left atrial reservoir”

    HumansLong-standing HIV infection without previous cardiovascular disease; compared with matched controlsleft ventricle, right ventricular free wall, and left atrial reservoir78.2% mensn = 110

    Long-term subclinical cardiac damage in people living with human inmunodeficiency virus.

    ESC Congress 2026 abstract

More on HIV infection

Prediabetes and early type 2 diabetes mellitus

upin humans1

1 study
  1. Prediabetes and early type 2 diabetes mellitus is associated with global longitudinal strain in humans.

    “GLS became progressively less negative across the dysglycemic groups (p < 0.001), consistent with reduced longitudinal myocardial deformation.”

    HumansPrediabetes and newly diagnosed type 2 diabetes mellitus (≤ 2 years), compared with healthy controlsleft ventriclen = 180

    Cardio-renal dysfunction in prediabetes and early type 2 diabetes: insights from myocardial strain and renal Doppler assessment

    BMC cardiovascular disorders

More on Prediabetes and early type 2 diabetes mellitus

All 23

Latest

Dec 2025: 5Jan 2026: 13Feb 2026: 10Mar 2026: 11Apr 2026: 2May 2026: 0Jun 2026: 1Jul 2026: 6Aug 2026: 6Sep 2026: 9Oct 2026: 44Nov 2026: 20127 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Blocking a collagen-linking enzyme improved heart failure in rats

Male rats with heart failure had heart relaxation times of 25.24 milliseconds with the inhibitor, compared with 27.20 milliseconds without it.Male rats with heart failure had heart relaxation times of 25.24 milliseconds with the inhibitor, compared with 27.20 milliseconds without it.

Rat studyMechanisms
AHA Scientific Sessions 2026 Abstract

Heart, kidney and metabolic burden linked to later heart risk

An observational analysis of 2,968 CARDIA participants and 4,294 MESA participants linked accumulated burden to unfavorable heart structure and function and higher…An observational analysis of 2,968 CARDIA participants and 4,294 MESA participants linked accumulated burden to unfavorable heart structure and function and higher cardiovascular event risk.

See all 196 papers on global longitudinal strain